Built for real routines. Written for serious scrutiny.
The difference is not a louder claim. It is the context behind it.
A supplement should not make you decode the label, hunt for the dose, or mistake one promising study for a guarantee. Lullo starts with five questions: what is it, what form is it, how much is there, what does human research measure, and what is still unknown?
Research cited here concerns dietary ingredients and defined preparations. Unless a source explicitly says otherwise, it did not test a finished Lullo product.
01 / Why Lullo
THE LULLO STANDARD
Less mystery between the front of the bottle and the facts panel.
The supplement aisle is very good at compressing a complicated subject into one oversized promise. We take the opposite approach. The label is the starting point, not the fine print.
Our goal is to make the decision useful: name the active ingredient or botanical, identify the form or preparation when it matters, show the serving amount, explain the intended support, and link the research used for ingredient education. When evidence is early, population-specific, or based on a biomarker rather than a felt outcome, we say so.
That is our advantage: not pretending uncertainty disappeared, but organizing it so you can make a better choice.
Identity before trend
“Magnesium,” “mushroom,” or “probiotic” is not enough context. Chemical form, botanical species and part, extract preparation, and microbial strain can change how relevant a study is to a product.
Amount before adjective
Words such as potent, advanced, and clinical are not units of measure. We prioritize the amount per serving and the serving directions so the label can be compared with the research.
Evidence with its limits intact
An ingredient study is not automatically a finished-product study. Statistical significance is not a guaranteed personal result. A biomarker is not always a clinical outcome. Context stays attached.
02 / Certificates of Analysis
LOT-SPECIFIC QUALITY DOCUMENTS
Request the document tied to your bottle.
Certificates of Analysis and related quality records can be specific to a production lot. Send us the details below and we will identify the customer-shareable document that matches your product, when available.
Request lot documentation-
01
Product name
Use the name printed on the front of the bottle.
-
02
Lot or batch number
Copy the code printed on the bottle or package so we can match the correct production record.
-
03
Order number
Include your Lullo order number so our team can verify the product and fulfillment details.
Before you request: document availability depends on the product, lot, and release status. We only share documents approved for customer distribution and will confirm what is available for the lot requested.
03 / The evidence framework
HOW WE READ A FORMULA
Six filters between a promising ingredient and a responsible claim.
One paper can be interesting. A decision needs more: a defined ingredient, a relevant dose, a credible study design, a useful outcome, an applicable population, and an honest read of uncertainty.
-
01
Ingredient identity
We ask whether the study used the same chemical form, botanical species, plant part, extract, strain, or ratio discussed on the product page. Similar names do not always mean interchangeable preparations.
-
02
Dose and exposure
We compare amount per serving, daily intake, frequency, and study duration. An acute caffeine study, an eight-week botanical trial, and a year-long nutrient study answer different questions.
-
03
Study design
Randomization, a suitable control, blinding, preregistered outcomes, and adequate sample size reduce bias. Systematic reviews can reveal the pattern across studies, but their conclusions are only as strong as the included trials.
-
04
Outcome relevance
We separate subjective scores, performance tests, blood levels, and clinical outcomes. A change in a laboratory marker can be biologically interesting without proving a noticeable everyday benefit.
-
05
Population fit
Age, training status, baseline nutrient status, health condition, medication use, diet, and sleep can influence results. A finding in older adults with low status may not transfer directly to a nutrient-replete young athlete.
-
06
Uncertainty and safety
We look for confidence intervals, consistency, adverse-event reporting, interaction warnings, and study limitations. “More research is needed” is useful information—not a line to hide.
04 / Ingredient landscape
WHAT THE HUMAN RESEARCH CAN ACTUALLY TELL US
Different goals. Different outcomes. Different levels of certainty.
This is a map of the questions researchers study—not a promise that every person will experience every reported outcome.
PERFORMANCE + HYDRATION
Creatine monohydrate and electrolytes
What is measured: repeated high-intensity performance, strength, training adaptation, body mass, fluid balance, and post-exercise rehydration.
What matters: creatine monohydrate is the most widely studied creatine form. The NIH notes that responses vary by person and that the strongest performance context is repeated short, intense effort—not every endurance scenario. For hydration, sweat loss, exercise duration, heat, sodium intake, and total fluid all change the question.
SLEEP + STRESS
Magnesium and ashwagandha
What is measured: sleep-onset latency, sleep quality scores, total sleep time, perceived stress, cortisol, and morning alertness.
What matters: the Supplement Facts panel reports elemental magnesium, not the full weight of the magnesium compound, and absorption varies by form. Sleep evidence for magnesium remains limited and population-specific. Ashwagandha trials use different root or root-and-leaf preparations and withanolide profiles; NCCIH describes some evidence for stress and insomnia while emphasizing small samples, preparation differences, and safety considerations.
FOCUS + STEADY ENERGY
Tea compounds and Lion’s Mane
What is measured: reaction time, attention switching, vigilance, mood, memory tasks, and perceived stress.
What matters: caffeine and L-theanine have been studied alone and together, often as acute interventions with outcomes measured within hours. A 2025 systematic review found small-to-moderate signals on selected cognition and mood outcomes while repeatedly noting uncertainty. Human Lion’s Mane research is much smaller; preparation, fruiting body versus mycelium, extract ratio, duration, and participant age limit broad conclusions.
Tea compounds systematic review · Lion’s Mane randomized trial
DIGESTION + IMMUNE SUPPORT
Probiotics and bovine colostrum
What is measured: digestive symptoms, stool frequency, microbiome composition, strain survival, immune markers, respiratory-symptom days, and intestinal-permeability markers.
What matters: probiotic evidence is strain-, dose-, and condition-specific. A result for one strain cannot simply be assigned to another. Colostrum research in athletes includes permeability and immune-related endpoints, but studies vary substantially in dose, protocol, sample size, and findings. A biomarker shift does not automatically establish improved performance or how someone will feel.
HEART + BONE
EPA/DHA, vitamin D, vitamin K, and calcium
What is measured: omega-3 index, triglycerides, cardiovascular events, serum 25-hydroxyvitamin D, calcium balance, bone-mineral density, and fracture outcomes.
What matters: nutrient status and baseline intake change the expected response. EPA and DHA are distinct long-chain omega-3 fatty acids, so total “fish oil” weight is not the same as EPA plus DHA content. For vitamin D, serum 25(OH)D is the main status marker, yet a biomarker level and a clinical outcome are not interchangeable.
CELLULAR ENERGY + HEALTHY AGING
NMN, NAD+ biology, and resveratrol
What is measured: blood NAD+ metabolites, glucose and lipid markers, physical-performance tests, endothelial measures, cerebral blood flow, tolerability, and adverse events.
What matters: “supports healthy aging” is not the same as proving a longer life or preventing age-related disease. Human NMN studies are generally short and modest in size; a 2024 meta-analysis found no significant benefit for the glucose and lipid outcomes it pooled. Resveratrol has been studied across many populations and endpoints, but a broad systematic review concluded that evidence is not yet conclusive enough for clinical recommendation. We treat these as emerging areas, not settled outcomes.
05 / Research vocabulary
TERMINOLOGY WITHOUT THE THEATER
The words that change how a study should be read.
- Bioavailability
- The proportion of an ingested substance that becomes available to the body. Higher absorption does not automatically mean a better outcome.
- Elemental amount
- The amount of the mineral itself, separate from the full weight of the compound it is bound to. This distinction is especially important for minerals such as magnesium and calcium.
- Standardized extract
- A botanical preparation made to contain a defined amount or range of selected constituents. Standardized extracts can still differ in plant part, solvent, ratio, and overall chemical profile.
- CFU
- Colony-forming units, an estimate of viable microorganisms in a probiotic. CFU count alone does not establish that a specific strain produces a specific benefit.
- Randomized controlled trial (RCT)
- A study that assigns participants to intervention and comparison groups by chance. Randomization helps reduce systematic differences between groups.
- Placebo-controlled
- A design comparing an intervention with an inactive or matched control, helping separate the intervention effect from expectations and normal variation.
- Double-blind
- A design in which participants and study personnel assessing outcomes do not know the assigned group, reducing expectation and observer bias.
- Systematic review
- A structured search and evaluation of the available studies using predefined methods. It is broader than a narrative selection of favorable papers.
- Meta-analysis
- A statistical synthesis of results from multiple studies. Pooling can improve precision, but it cannot erase poor study quality or major differences between trials.
- Confidence interval (CI)
- A range describing the uncertainty around an estimated effect. A wide interval usually means less precision; it can include effects that are trivial, meaningful, or in the opposite direction.
- Surrogate endpoint
- A marker used in place of a direct clinical outcome—for example, a blood value instead of how a person feels, functions, or performs.
- External validity
- How well a study’s result is likely to generalize beyond its exact participants, setting, dose, duration, and protocol.
06 / Read a study in seven questions
A PRACTICAL CHECKLIST
Do not stop at the abstract’s last sentence.
A research citation should make a claim easier to inspect. It should not function as decoration.
- 01
Who was studied? Look at age, sex, health status, training level, baseline nutrient status, and sample size.
- 02
What exactly was used? Match the ingredient form, extract, strain, dose, timing, and duration.
- 03
What was the comparison? Placebo, no treatment, a different nutrient, or an active treatment answer different questions.
- 04
What was measured? Separate performance tests, symptom scales, biomarkers, diagnoses, and adverse events.
- 05
How large was the effect? A small statistically significant change may not be noticeable or meaningful.
- 06
How certain is the estimate? Check confidence intervals, missing data, risk of bias, and whether studies agree.
- 07
Who funded it and was it replicated? Funding does not automatically invalidate a study, but transparency and independent replication matter.
07 / What we will not imply
TRUST NEEDS BOUNDARIES
We would rather state the limitation than sell around it.
- An ingredient study does not prove the finished Lullo formula produced the study result.
- A mechanism observed in cells or animals does not establish the same outcome in humans.
- A rise or fall in a biomarker does not automatically mean better health, performance, or longevity.
- A statistically significant group average does not guarantee an individual response.
- “Natural” does not mean interaction-free, side-effect-free, or appropriate during pregnancy, surgery, or medication use.
- A supplement does not replace a varied diet, training, sleep, prescribed care, or medical advice.
08 / Source index
START WITH THE SOURCE, NOT OUR SUMMARY
Primary literature and authoritative public-health references.
Product pages contain additional ingredient-specific reading. The list below supports the framework and evidence landscape in this brief.
-
Government guidance
FDA 101: Dietary Supplements
Premarket approval, labeling responsibility, safety, interactions, and informed use.
-
Government guidance
FDA Questions and Answers on Dietary Supplements
Structure/function claims, claim substantiation, and required disclaimers.
-
NIH fact sheet
Dietary Supplements for Exercise and Athletic Performance
Creatine forms, common research doses, performance context, and safety summary.
-
NIH fact sheet
Magnesium — Health Professional Fact Sheet
Elemental magnesium, supplement forms, bioavailability, upper limits, and interactions.
-
Systematic review
Oral magnesium supplementation for insomnia in older adults
Three small RCTs; low-to-very-low certainty and population-specific sleep findings.
-
Government review
NCCIH: Ashwagandha — Usefulness and Safety
Preparation differences, evidence summary, short-term safety, and interaction cautions.
-
Systematic review
Effect of Ashwagandha extract on sleep
Five randomized trials with small pooled sleep effects and limited long-term safety data.
-
Systematic review
Tea, L-theanine, caffeine, cognition, sleep, and mood
Randomized-trial synthesis with selected short-term signals and material uncertainty.
-
Randomized trial
Acute standardized Lion’s Mane extract in healthy younger adults
A small crossover trial illustrating the early, preparation-specific human evidence base.
-
Government review
NCCIH: Probiotics — Usefulness and Safety
Strain specificity, evidence gaps, populations, and safety considerations.
-
Systematic review
Bovine colostrum and intestinal-permeability markers
Meta-analysis of randomized trials with heterogeneity and a call for more dose- and duration-specific research.
-
NIH fact sheet
Omega-3 Fatty Acids — Health Professional Fact Sheet
EPA, DHA, sources, health outcomes, dosage context, and medication interactions.
-
NIH fact sheet
Vitamin D — Health Professional Fact Sheet
Metabolism, serum 25(OH)D, bone health, evidence limits, safety, and interactions.
-
Systematic review
NMN and glucose and lipid metabolism in adults
Eight short RCTs and no significant pooled benefit for the reported metabolic outcomes.
-
Systematic review
Resveratrol clinical trials: gaps and opportunities
A broad clinical-trial review finding substantial interest but no conclusive basis for clinical recommendation.
Put the framework to work
Find the formula that fits your goal.
Use the same decision process we describe above: start with your goal, then narrow by caffeine preference and the kind of starting point you want. Your result is a starting point, not medical advice.
